Breast_Cancer News
|
HDL-cholesterol and breast cancer risk Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy. Friday, January 24th, 2020 |
|
Study finds breast cancer recurrence score has different implications for men A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer Monday, December 23rd, 2019 |
|
Pietenpol, Wilson land Komen cancer research support Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research. Thursday, October 24th, 2019 |
|
Another way to detect lymphedema Early detection of lymphedema, which occurs in 20% of patients following breast cancer treatment, may improve therapeutic options for patients. Tuesday, October 22nd, 2019 |
|
Study finds men have higher mortality rate after breast cancer diagnosis A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease. Thursday, October 17th, 2019 |
|
Study backs genetic testing for all metastatic breast cancer patients Testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies. Friday, September 6th, 2019 |
|
Grant strengthens breast cancer research efforts Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding. Saturday, August 31st, 2019 |
|
A “rheostat” for cancer signals Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells. Friday, August 30th, 2019 |
|
Clinical study tests drug that may prevent cancer metastasis A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center. Thursday, July 11th, 2019 |
|
Technology better than tape measure for identifying lymphedema risk Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study. Friday, May 17th, 2019 |
|
Like racecars and geese, cancer cells draft their way to new tumor sites Finding gives boost to fighting cancer through cell metabolism Friday, April 5th, 2019 |
|
Breast cancer-killing RIG A recent study in the journal Cancer Research demonstrates that a RIG-I agonist has potent immunogenic and therapeutic effects in breast cancer. Friday, December 14th, 2018 |
|
Mary Kay Foundation grant to bolster immunotherapy research Charles Caskey, Ph.D., has received a cancer research grant from The Mary Kay Foundation to study how focused ultrasound therapy could be an ideal helper for immunotherapy. Monday, October 22nd, 2018 |
|
VICC breast cancer leaders named Komen Scholars Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program, has been named a Komen Scholar for her leadership in breast cancer research. She is joined by Wayne Dornan, PhD, a patient research advocate at VICC, who will serve on the Advocates in Science Steering Committee for Susan G. Komen. Friday, April 13th, 2018 |
|
Study seeks to boost breast tumor immune response Targeting specific molecules in breast tumors, called methylating agents, can turn up the immune response, potentially making tumors responsive to immunotherapy, suggests a new study published in Nature Communications. Thursday, February 8th, 2018 |
|
Study to test combination therapy for breast cancer Vanderbilt-Ingram Cancer Center has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer. Friday, October 27th, 2017 |
|
Investigators match novel cancer mutations with potential therapies Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients. They identified a novel gene mutation that develops in the tumors, and then found a different cancer drug that appears to treat the newly identified mutation. The […] Monday, August 7th, 2017 |
|
Drivers of breast cancer metastasis Overexpression of HER2 (human epidermal growth factor receptor 2) is found in about 25 percent of breast cancers and is associated with poor outcomes. HER2-amplified breast cancers use signaling through a complex of proteins called mTORC2 to drive tumor formation, tumor cell survival and resistance to HER2-targeted therapies. Rebecca Cook, Ph. Thursday, July 27th, 2017 |
|
Arteaga to direct UT Southwestern cancer center Carlos L. Arteaga, M.D. Thursday, July 13th, 2017 |
|
Breast cancer program lands new research grants Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients. The grants totaling more than $3 million will fund mechanistic science and clinical trials designed to test novel therapy combinations and determine why some forms of breast cancer become resistant […] Friday, March 24th, 2017 |
|
Precision medicine already changing cancer treatment strategies The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. “Nationwide we’re seeing great promise with this approach […] Thursday, May 26th, 2016 |
|
|
Public invited to learn about VICC precision cancer medicine Leading cancer investigators from Vanderbilt-Ingram Cancer Center will unveil the latest in cancer research during an upcoming community event. “Precision Medicine in Cancer: At the Crossroads of Research and Treatment for Patients” will be held Tuesday, May 10, from 5: Friday, April 29th, 2016 |
|
|
Study explores how some breast cancers resist treatment A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies. The new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators has identified gene alterations […] Thursday, April 21st, 2016 |
|
VICC’s Balko named a Susan G. Komen ‘Pink Tie Guy’ Justin Balko, Pharm.D., Ph. Thursday, December 10th, 2015 |
|
Study seeks to ease ‘chemobrain’ for cancer patients Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment. And as the survival rates for breast cancer increase, so do these issues associated with chemotherapy. Paul Newhouse, M. Monday, August 24th, 2015 |
